المصدر: LUTATHERA Injection General Use Result Survey (Somatostatin Receptor-positive Neuroendocrine Tumor, CAAA601A11401)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05844332Test

المصدر: A Post Marketing Surveillance on Lutathera® (Lutetium (177Lu) Oxodotreotide, 177Lu-DOTA0-Tyr3-Octreotate) in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) in Korea

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04946305Test

المصدر: An Open-label Phase I Study Evaluating the Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs - The COOPERATE-1 Study

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01263353Test

Other URLs: https://www.novctrd.com/ctrdweb/trialresult/trialresults/pdf?trialResultId=13569Test

المصدر: Multicenter 3-arm Trial to Evaluate the Efficacy and Safety of Pasireotide LAR or Everolimus Alone or in Combination in Patients With Well Differentiated Neuroendocrine Carcinoma of the Lung and Thymus - LUNA Trial

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01563354Test

المصدر: A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01652547Test

Other URLs: https://www.novctrd.com/ctrdweb/trialresult/trialresults/pdf?trialResultId=14789Test

المصدر: A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02060383Test